by Mariam Kiparoidze | Dec 22, 2023
Photo by Afif Ramdhasuma on Unsplash Kristina Osborne had recently ended a long-term relationship when she accidentally swiped right for a guy she thought she had seen at her gym. She wasn’t looking for a relationship or a casual date. She thought Tinder could be a...
by Mariam Kiparoidze | Nov 30, 2023
Photo by Paul Steuber on Unsplash Riding on the momentum after the win with the big three automakers, the United Auto Workers union is launching a huge new quest to unionize workers at other carmakers like Tesla, but faces a staunch anti-union boss Elon Musk in its...
by Mariam Kiparoidze | Nov 27, 2023
Photo: Wikimedia Commons Covid made Pfizer a household name and sent its revenues and profits soaring. Now flush with cash and amid its post-covid slump, Pfizer is betting that its next blockbuster drug could be a cancer treatment. The pharma giant made headlines...
by Mariam Kiparoidze | Nov 3, 2023
Photo credit:Wikimedia Commons Pfizer reported a loss in the third quarter as it tries to adapt to the faltering demand on its Covid-19 drug and vaccines. Pfizer reported a net loss of $2.38 billion last quarter, missing analyst expectations, the pharmaceutical giant...
by Mariam Kiparoidze | Oct 3, 2023
Image by Mike Ramírez Mx from Pixabay Pharmaceutical giant Pfizer has teamed up with a biology biotech company Ginkgo Bioworks to research and develop RNA medicines, following a series of acquisitions and partnerships to grow and diversify its portfolio With...
